Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
KIDS Stock Forecast 2025-2026
$18.41
Current Price
$461.67M
Market Cap
Buy 6
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to KIDS Price Targets
+84.7%
To High Target of $34.00
+24.9%
To Median Target of $23.00
+3.2%
To Low Target of $19.00
KIDS Price Momentum
-0.4%
1 Week Change
+8.2%
1 Month Change
-20.5%
1 Year Change
-20.6%
Year-to-Date Change
-33.3%
From 52W High of $27.60
+20.5%
From 52W Low of $15.28
📊 TOP ANALYST CALLS
Did KIDS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if OrthoPediatrics is one of their latest high-conviction picks.
Latest KIDS Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, KIDS has a bullish consensus with a median price target of $23.00 (ranging from $19.00 to $34.00). The overall analyst rating is N/A (N/A/10). Currently trading at $18.41, the median forecast implies a 24.9% upside. This outlook is supported by 6 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Ben Haynor at Lake Street, projecting a 84.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
KIDS Analyst Ratings
6
Buy
1
Hold
0
Sell
KIDS Price Target Range
Low
$19.00
Average
$23.00
High
$34.00
Current: $18.41
Latest KIDS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for KIDS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Oct 29, 2025 | Needham | Mike Matson | Buy | Maintains | $26.00 |
| Oct 29, 2025 | BTIG | Ryan Zimmerman | Buy | Reiterates | $23.00 |
| Oct 10, 2025 | Lake Street | Ben Haynor | Buy | Maintains | $34.00 |
| Oct 10, 2025 | Stifel | Rick Wise | Buy | Maintains | $20.00 |
| Oct 10, 2025 | JMP Securities | David Turkaly | Market Outperform | Maintains | $25.00 |
| Oct 10, 2025 | BTIG | Ryan Zimmerman | Buy | Maintains | $23.00 |
| Oct 10, 2025 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $22.00 |
| Aug 8, 2025 | JMP Securities | David Turkaly | Market Outperform | Maintains | $35.00 |
| Aug 6, 2025 | BTIG | Ryan Zimmerman | Buy | Maintains | $39.00 |
| May 8, 2025 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $30.00 |
| May 8, 2025 | Needham | Mike Matson | Buy | Reiterates | $42.00 |
| Apr 11, 2025 | Truist Securities | Richard Newitter | Hold | Maintains | $24.00 |
| Apr 9, 2025 | Needham | Mike Matson | Buy | Reiterates | $42.00 |
| Apr 7, 2025 | Lake Street | Ben Haynor | Buy | Initiates | $37.00 |
| Mar 21, 2025 | Citizens Capital Markets | David Turkaly | Market Outperform | Reiterates | $50.00 |
| Mar 5, 2025 | Stifel | Rick Wise | Buy | Maintains | $32.00 |
| Mar 5, 2025 | Needham | Mike Matson | Buy | Reiterates | $42.00 |
| Jan 14, 2025 | Needham | Mike Matson | Buy | Reiterates | $42.00 |
| Dec 18, 2024 | Truist Securities | Richard Newitter | Hold | Maintains | $25.00 |
| Nov 8, 2024 | Needham | Mike Matson | Buy | Reiterates | $42.00 |
OrthoPediatrics Corp. (KIDS) Competitors
The following stocks are similar to OrthoPediatrics based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
KIDS
OrthoPediatrics
mkt cap
461.67M
OrthoPediatrics Corp. (KIDS) Financial Data
OrthoPediatrics Corp. has a market capitalization of $461.67M with a P/E ratio of 246.3x. The company generates $227.41M in trailing twelve-month revenue with a -20.1% profit margin.
Revenue growth is +12.2% quarter-over-quarter, while maintaining an operating margin of -7.9% and return on equity of -12.7%.
Valuation Metrics
Market Cap
$461.67M
Enterprise Value
$503.29M
P/E Ratio
246.3x
PEG Ratio
5.2x
Price/Sales
2.0x
Growth & Margins
Revenue Growth (YoY)
+12.2%
Gross Margin
+73.9%
Operating Margin
-7.9%
Net Margin
-20.1%
EPS Growth
+12.2%
Financial Health
Cash/Price Ratio
+12.5%
Current Ratio
7.4x
Debt/Equity
28.4x
ROE
-12.7%
ROA
-4.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
OrthoPediatrics Corp. (KIDS) Business Model
About OrthoPediatrics Corp.
What They Do
Develops orthopedic devices for pediatric patients.
Business Model
OrthoPediatrics Corp. generates revenue by designing, manufacturing, and selling specialized orthopedic medical devices tailored specifically for children. The company targets hospitals and orthopedic surgeons, providing them with innovative solutions for various pediatric musculoskeletal conditions, including trauma, deformity correction, and spine issues.
Additional Information
The company operates globally, focusing on a niche market that is often overlooked in the medical device industry. By prioritizing child-specific designs, OrthoPediatrics aims to enhance safety and efficacy in pediatric care, contributing to improved long-term outcomes for young patients.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
562
CEO
Mr. David R. Bailey
Country
United States
IPO Year
2017
Website
www.orthopediatrics.comOrthoPediatrics Corp. (KIDS) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Nov 26, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet
11 days ago
Quick Summary
Wall Street analysts' average price target suggests a 26.5% upside for OrthoPediatrics (KIDS). Positive earnings estimate revisions may support this potential increase.
Why It Matters
The 26.5% potential upside in OrthoPediatrics' stock, backed by positive earnings revisions, suggests growth opportunities, attracting investor interest despite skepticism around price targets.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) announced the launch of two new products, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems, expanding its OPSB portfolio to 31 systems.
Why It Matters
The launch of new products expands OrthoPediatrics' market offerings, potentially increasing revenue and market share in pediatric orthopedics, which can positively influence stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Wall Street Analysts Believe OrthoPediatrics (KIDS) Could Rally 41.92%: Here's is How to Trade
27 days ago
Quick Summary
OrthoPediatrics (KIDS) has a consensus price target indicating a 41.9% upside potential. Upward revisions in earnings estimates may suggest near-term stock gains.
Why It Matters
A 41.9% upside potential signals strong growth prospects for OrthoPediatrics, while upward earnings revisions suggest positive market sentiment and potential stock appreciation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) will participate in three upcoming investor conferences, focusing on advancements in pediatric orthopedics.
Why It Matters
OrthoPediatrics' participation in investor conferences may enhance visibility and attract potential investors, signaling growth opportunities in pediatric orthopedics.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
OrthoPediatrics Corp. (NASDAQ: KIDS) will hold its Q3 2025 earnings call on October 28, 2025, at 4:30 PM EDT, featuring CEO David Bailey and CFO Fred Hite.
Why It Matters
The earnings call provides insights into OrthoPediatrics' financial performance and strategic direction, crucial for assessing investment potential and market positioning.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) reported its financial results for Q3 2025, focusing on advancements in pediatric orthopedics. Further details on performance are pending.
Why It Matters
OrthoPediatrics' Q3 financial results may impact stock performance, reflecting growth or challenges in pediatric orthopedics, which influences investor sentiment and future valuation.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About KIDS Stock
What is OrthoPediatrics Corp.'s (KIDS) stock forecast for 2026?
Based on our analysis of 10 Wall Street analysts, OrthoPediatrics Corp. (KIDS) has a median price target of $23.00. The highest price target is $34.00 and the lowest is $19.00.
Is KIDS stock a good investment in 2026?
According to current analyst ratings, KIDS has 6 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $18.41. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for KIDS stock?
Wall Street analysts predict KIDS stock could reach $23.00 in the next 12 months. This represents a 24.9% increase from the current price of $18.41. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is OrthoPediatrics Corp.'s business model?
OrthoPediatrics Corp. generates revenue by designing, manufacturing, and selling specialized orthopedic medical devices tailored specifically for children. The company targets hospitals and orthopedic surgeons, providing them with innovative solutions for various pediatric musculoskeletal conditions, including trauma, deformity correction, and spine issues.
What is the highest forecasted price for KIDS OrthoPediatrics Corp.?
The highest price target for KIDS is $34.00 from Ben Haynor at Lake Street, which represents a 84.7% increase from the current price of $18.41.
What is the lowest forecasted price for KIDS OrthoPediatrics Corp.?
The lowest price target for KIDS is $19.00 from at , which represents a 3.2% increase from the current price of $18.41.
What is the overall KIDS consensus from analysts for OrthoPediatrics Corp.?
The overall analyst consensus for KIDS is bullish. Out of 10 Wall Street analysts, 6 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $23.00.
How accurate are KIDS stock price projections?
Stock price projections, including those for OrthoPediatrics Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 7, 2025 9:11 AM UTC